What is Nano Labs' operating income?

Nano Labs' total operating income in 2025 was $10.21 million, based on the following breakdown: Total Gross Profit: -$5.69 million Total Operating Expenses: -$15.90 million

Nano Labs (NA) Financials

$1.93 +0.01 (+0.52%)

Closing price 07/24/2026 03:58 PM Eastern

Extended Trading

$1.83 -0.10 (-5.18%)

As of 07/24/2026 07:34 PM Eastern

Compare

Annual Income Statements for Nano Labs

This table shows Nano Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-5.80	-27	4.51	-36	-16	19
Consolidated Net Income / (Loss)	-5.80	-27	4.51	-36	-16	18
Net Income / (Loss) Continuing Operations	-5.80	-27	4.51	-36	-16	18
Total Pre-Tax Income	-5.80	-27	4.51	-36	-16	18
Total Operating Income	-5.68	-28	3.00	-37	-16	10
Total Gross Profit	0.13	-0.64	33	-15	1.59	-5.69
Total Revenue	0.33	6.19	143	11	5.56	3.86
Operating Revenue	0.33	6.19	143	11	5.56	3.86
Total Cost of Revenue	0.20	6.83	109	26	3.97	9.55
Operating Cost of Revenue	0.20	6.83	109	26	3.97	9.55
Total Operating Expenses	5.81	27	30	22	17	-16
Selling, General & Admin Expense	0.49	3.79	7.71	7.52	6.96	7.81
Marketing Expense	0.02	0.80	3.54	2.16	1.25	0.67
Research & Development Expense	5.30	23	19	12	6.87	1.15
Other Operating Expenses / (Income)	-	-	-	0.00	2.16	-26
Total Other Income / (Expense), net	-0.12	0.60	1.51	0.90	-0.72	7.80
Interest Expense	-	-	0.00	0.00	0.95	2.42
Interest & Investment Income	0.00	0.55	0.29	0.07	0.07	0.01
Other Income / (Expense), net	-0.12	0.05	1.22	0.83	0.15	10
Income Tax Expense	0.00	0.00	0.00	-0.00	0.00	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-	0.00	0.00	-0.22	-0.87	-1.36
Basic Earnings per Share	($0.48)	($0.61)	$0.85	($6.05)	($1.93)	$0.98
Weighted Average Basic Shares Outstanding	79.25M	44.94M	5.32M	5.89M	8.05M	19.86M
Diluted Earnings per Share	($0.48)	($0.61)	$0.85	($6.05)	($1.93)	$0.98
Weighted Average Diluted Shares Outstanding	79.25M	44.94M	5.33M	5.89M	8.05M	19.86M
Weighted Average Basic & Diluted Shares Outstanding	-	-	111.50M	65.83M	15.67M	23.50M

No quarterly income statements for Nano Labs are available.

This table details how cash moves in and out of Nano Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	3.80	31	-21	-5.51	-2.16	-3.16
Net Cash From Operating Activities	-0.47	11	-40	-19	-19	-15
Net Cash From Continuing Operating Activities	-0.47	11	-40	-19	-19	-15
Net Income / (Loss) Continuing Operations	-5.80	-27	4.51	-36	-16	18
Consolidated Net Income / (Loss)	-5.80	-27	4.51	-36	-16	18
Depreciation Expense	0.05	0.41	0.57	0.62	1.32	1.57
Amortization Expense	0.04	0.46	0.80	0.81	0.27	0.17
Non-Cash Adjustments To Reconcile Net Income	6.96	138	-87	8.68	2.46	-24
Changes in Operating Assets and Liabilities, net	-1.72	-100	41	6.92	-6.76	-11
Net Cash From Investing Activities	-0.25	-5.66	-4.81	-15	-35	-42
Net Cash From Continuing Investing Activities	-0.25	-5.66	-4.81	-15	-35	-42
Purchase of Property, Plant & Equipment	-0.14	-1.28	-2.54	-15	-4.98	-0.01
Purchase of Investments	-0.35	-5.08	-	0.00	-	-0.29
Sale of Property, Plant & Equipment	-	-	0.00	0.00	0.00	0.26
Other Investing Activities, net	-	-	-	0.00	-30	-42
Net Cash From Financing Activities	4.52	26	23	28	52	55
Net Cash From Continuing Financing Activities	4.52	26	23	28	52	55
Repayment of Debt	-0.14	-5.70	-0.02	-0.22	-23	-3.34
Repurchase of Common Equity	-	-	-	0.00	0.00	-0.24
Issuance of Debt	4.65	0.00	2.48	18	30	7.17
Issuance of Common Equity	0.00	32	21	10	43	51
Other Financing Activities, net	0.00	0.01	0.00	0.00	1.37	0.04
Cash Interest Paid	0.00	0.00	0.03	0.53	1.27	1.51
Cash Income Taxes Paid	0.00	0.04	0.01	0.00	0.00	0.00

No quarterly cash flow statements for Nano Labs are available.

This table presents Nano Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	143	53	49	84	160
Total Current Assets	140	42	18	46	62
Cash & Equivalents	37	13	6.78	4.44	1.22
Restricted Cash	0.00	0.01	0.06	0.06	0.19
Short-Term Investments	5.00	-	-	0.00	3.75
Accounts Receivable	-	0.00	0.24	0.08	0.04
Inventories, net	34	15	1.81	4.09	1.96
Prepaid Expenses	58	10	3.43	0.63	1.08
Other Current Assets	6.51	3.95	5.34	37	53
Plant, Property, & Equipment, net	1.14	3.11	24	27	26
Total Noncurrent Assets	1.44	8.29	7.77	11	72
Long-Term Investments	-	-	-	0.00	0.29
Noncurrent Note & Lease Receivables	-	-	-	3.97	4.35
Intangible Assets	0.00	7.06	6.72	6.40	6.54
Other Noncurrent Operating Assets	1.44	1.22	1.05	0.71	61
Total Liabilities & Shareholders' Equity	143	53	49	84	160
Total Liabilities	147	29	52	52	54
Total Current Liabilities	146	27	34	29	29
Short-Term Debt	0.00	0.04	3.30	3.20	8.84
Accounts Payable	0.45	2.22	2.38	2.48	2.78
Other Current Liabilities	1.91	24	28	23	7.93
Total Noncurrent Liabilities	0.33	2.78	17	24	35
Long-Term Debt	-	2.42	17	23	24
Noncurrent Deferred Revenue	-	-	-	-	9.91
Other Noncurrent Operating Liabilities	0.33	0.36	0.53	0.40	0.24
Total Equity & Noncontrolling Interests	-3.87	24	-2.29	32	106
Total Preferred & Common Equity	-3.87	24	-2.08	32	107
Total Common Equity	-3.87	24	-2.08	32	107
Common Stock	32	51	60	107	169
Retained Earnings	-35	-29	-64	-77	-61
Treasury Stock	-	-	-	0.00	-0.24
Accumulated Other Comprehensive Income / (Loss)	-0.39	0.30	0.32	1.18	-1.07
Other Equity Adjustments	0.00	0.96	0.94	0.91	0.95
Noncontrolling Interest	-	0.00	-0.22	0.29	-1.06

No quarterly balance sheets for Nano Labs are available.

This table displays calculated financial ratios and metrics derived from Nano Labs' official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	0.00	0.00	111,496,668.00	111,496,668.00	131,662,874.00	131,662,874.00
DEI Adjusted Shares Outstanding	0.00	0.00	11,149,667.00	11,149,667.00	13,166,287.00	13,166,287.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	0.00	0.40	-3.19	-1.18	1.47
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	1,792.16%	2,203.17%	-92.26%	-49.59%	-30.56%
EBITDA Growth	0.00%	-375.60%	120.60%	-716.65%	59.65%	259.40%
EBIT Growth	0.00%	-382.70%	115.07%	-950.41%	56.82%	231.79%
NOPAT Growth	0.00%	-394.12%	115.27%	-957.36%	57.38%	193.17%
Net Income Growth	0.00%	-373.40%	116.43%	-894.02%	54.29%	209.97%
EPS Growth	0.00%	-27.17%	116.43%	-894.02%	68.15%	150.63%
Operating Cash Flow Growth	0.00%	2,517.07%	-454.13%	52.84%	-1.54%	18.89%
Free Cash Flow Firm Growth	0.00%	0.00%	-316.45%	58.57%	-131.52%	-29.23%
Invested Capital Growth	0.00%	0.00%	129.75%	-18.11%	386.29%	147.80%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	40.26%	-10.37%	23.41%	-132.06%	28.58%	-147.33%
EBITDA Margin	-1,744.18%	-438.40%	3.92%	-312.35%	-250.02%	573.94%
Operating Margin	-1,735.85%	-453.30%	2.10%	-332.91%	-281.45%	264.35%
EBIT Margin	-1,773.47%	-452.42%	2.96%	-325.34%	-278.67%	528.90%
Profit (Net Income) Margin	-1,772.91%	-443.56%	3.17%	-324.70%	-294.46%	466.36%
Tax Burden Percent	100.01%	100.00%	100.00%	99.99%	100.00%	100.00%
Interest Burden Percent	99.96%	98.04%	106.89%	99.81%	105.67%	88.17%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	-208.53%	-33.67%	10.87%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	-858.38%	-64.22%	42.13%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	-123.99%	-76.92%	15.26%
Return on Equity (ROE)	0.00%	709.38%	45.19%	-332.52%	-110.59%	26.13%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-414.01%	-188.62%	-165.44%	-74.12%
Operating Return on Assets (OROA)	0.00%	-19.61%	4.31%	-69.98%	-23.18%	16.71%
Return on Assets (ROA)	0.00%	-19.23%	4.60%	-69.84%	-24.49%	14.73%
Return on Common Equity (ROCE)	0.00%	709.38%	45.19%	-335.84%	-110.31%	26.27%
Return on Equity Simple (ROE_SIMPLE)	0.00%	709.38%	18.93%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-3.97	-20	3.00	-26	-11	10
NOPAT Margin	-1,215.10%	-317.31%	2.10%	-233.04%	-197.01%	264.35%
Net Nonoperating Expense Percent (NNEP)	0.00%	-37.48%	5.82%	649.85%	30.56%	-31.25%
Return On Investment Capital (ROIC_SIMPLE)	-	-	11.40%	-143.28%	-18.73%	7.33%
Cost of Revenue to Revenue	59.74%	110.37%	76.59%	232.06%	71.42%	247.33%
SG&A Expenses to Revenue	149.86%	61.16%	5.41%	68.17%	125.22%	202.19%
R&D to Revenue	1,621.14%	368.79%	13.41%	113.11%	123.52%	29.84%
Operating Expenses to Revenue	1,776.11%	442.93%	21.31%	200.85%	310.03%	-411.69%
Earnings before Interest and Taxes (EBIT)	-5.80	-28	4.22	-36	-15	20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-5.71	-27	5.59	-34	-14	22
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.85	0.00	1.86	0.19
Price to Tangible Book Value (P/TBV)	0.00	0.00	1.21	0.00	2.34	0.21
Price to Revenue (P/Rev)	62.23	3.29	0.14	0.00	10.60	5.37
Price to Earnings (P/E)	0.00	0.00	4.51	0.00	0.00	1.07
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	22.17%	0.00%	0.00%	93.42%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.74	0.00	1.51	0.36
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.07	0.00	14.62	12.30
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	1.80	0.00	0.00	2.14
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	2.39	0.00	0.00	2.33
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	3.36	0.00	0.00	4.65
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.10	-8.84	0.83	0.31
Long-Term Debt to Equity	0.00	0.00	0.10	-7.40	0.73	0.23
Financial Leverage	0.00	10.78	-2.60	0.14	1.20	0.36
Leverage Ratio	0.00	-36.89	9.82	4.76	4.51	1.77
Compound Leverage Factor	0.00	-36.17	10.49	4.75	4.77	1.56
Debt to Total Capital	0.00%	0.00%	9.35%	112.76%	45.45%	23.90%
Short-Term Debt to Total Capital	0.00%	0.00%	0.15%	18.37%	5.47%	6.35%
Long-Term Debt to Total Capital	0.00%	0.00%	9.19%	94.39%	39.98%	17.55%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	-1.20%	0.50%	-0.76%
Common Equity to Total Capital	0.00%	100.00%	90.65%	-11.56%	54.06%	76.86%
Debt to EBITDA	0.00	0.00	0.44	-0.59	-1.91	1.50
Net Debt to EBITDA	0.00	0.00	-1.84	-0.39	-1.59	1.26
Long-Term Debt to EBITDA	0.00	0.00	0.43	-0.49	-1.68	1.10
Debt to NOPAT	0.00	0.00	0.82	-0.79	-2.43	3.26
Net Debt to NOPAT	0.00	0.00	-3.43	-0.52	-2.02	2.73
Long-Term Debt to NOPAT	0.00	0.00	0.81	-0.66	-2.13	2.39
Altman Z-Score	0.00	-0.92	2.94	0.00	-0.90	0.38
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	-1.00%	0.25%	-0.56%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	0.96	1.57	0.52	1.61	2.09
Quick Ratio	0.00	0.29	0.48	0.21	0.16	0.17
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	26	-56	-23	-54	-70
Operating Cash Flow to CapEx	-323.23%	880.95%	-1,568.30%	-126.54%	-383.29%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	-56.85	-28.73
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	-20.15	-6.39
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	-25.41	-6.29
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.04	1.45	0.22	0.08	0.03
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	34.39	65.06
Inventory Turnover	0.00	0.20	4.51	3.08	1.35	3.16
Fixed Asset Turnover	0.00	5.44	67.17	0.82	0.22	0.15
Accounts Payable Turnover	0.00	15.34	82.01	11.15	1.64	3.63
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	10.61	5.61
Days Inventory Outstanding (DIO)	0.00	1,793.28	80.87	118.55	271.31	115.59
Days Payable Outstanding (DPO)	0.00	23.79	4.45	32.75	223.15	100.45
Cash Conversion Cycle (CCC)	0.00	1,769.48	76.42	85.80	58.78	20.75
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	-46	14	11	54	134
Invested Capital Turnover	0.00	-0.27	-8.91	0.89	0.17	0.04
Increase / (Decrease) in Invested Capital	0.00	-46	59	-2.45	43	80
Enterprise Value (EV)	0.00	-21	10	0.00	81	48
Market Capitalization	20	20	20	0.00	59	21
Book Value per Share	$0.00	($0.09)	$4.48	($0.02)	$0.48	$5.39
Tangible Book Value per Share	$0.00	($0.09)	$3.15	($0.08)	$0.38	$5.06
Total Capital	0.00	-3.87	26	18	58	139
Total Debt	0.00	0.00	2.46	20	27	33
Total Long-Term Debt	0.00	0.00	2.42	17	23	24
Net Debt	0.00	-42	-10	13	22	28
Capital Expenditures (CapEx)	0.14	1.28	2.54	15	4.98	-0.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-48	2.53	-20	16	36
Debt-free Net Working Capital (DFNWC)	0.00	-6.11	15	-13	21	41
Net Working Capital (NWC)	0.00	-6.11	15	-16	18	32
Net Nonoperating Expense (NNE)	1.82	7.81	-1.51	10	5.42	-7.80
Net Nonoperating Obligations (NNO)	0.00	-42	-10	13	22	28
Total Depreciation and Amortization (D&A)	0.10	0.87	1.37	1.43	1.59	1.74
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-772.51%	1.77%	-181.59%	292.56%	928.04%
Debt-free Net Working Capital to Revenue	0.00%	-98.74%	10.71%	-119.57%	373.48%	1,061.58%
Net Working Capital to Revenue	0.00%	-98.74%	10.68%	-149.46%	315.96%	832.60%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$2.90	$0.00	($1.93)	$0.98
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	10.65M	0.00	8.05M	19.86M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$2.90	$0.00	($1.93)	$0.98
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	10.66M	0.00	8.05M	19.86M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	11.15M	0.00	15.67M	23.50M
Normalized Net Operating Profit after Tax (NOPAT)	-3.97	-20	2.10	-26	-11	7.15
Normalized NOPAT Margin	-1,215.10%	-317.31%	1.47%	-233.04%	-197.01%	185.05%
Pre Tax Income Margin	-1,772.80%	-443.56%	3.17%	-324.72%	-294.46%	466.36%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	-16.36	8.43
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	-11.57	4.21
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	-21.62	8.54
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	-16.83	4.32
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	1.32%

No quarterly metrics and ratios for Nano Labs are available.

Financials Breakdown Chart

Nano Labs Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Nano Labs' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Nano Labs' net income appears to be on a downward trend, with a most recent value of $18.01 million in 2025, falling from -$5.80 million in 2020. The previous period was -$16.38 million in 2024. Check out Nano Labs' forecast to explore projected trends and price targets.

Nano Labs' total operating income in 2025 was $10.21 million, based on the following breakdown:

Total Gross Profit: -$5.69 million
Total Operating Expenses: -$15.90 million

Over the last 5 years, Nano Labs' total revenue changed from $327.09 thousand in 2020 to $3.86 million in 2025, a change of 1,080.7%.

Nano Labs' total liabilities were at $54.14 million at the end of 2025, a 3.2% increase from 2024, and a 63.1% decrease since 2021.

In the past 4 years, Nano Labs' cash and equivalents has ranged from $1.22 million in 2025 to $36.70 million in 2021, and is currently $1.22 million as of their latest financial filing in 2025.

Over the last 5 years, Nano Labs' book value per share changed from 0.00 in 2020 to 5.39 in 2025, a change of 538.9%.

Related Companies

Financial statements for NASDAQ:NA last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nano Labs (NA) Financials

Financials Breakdown Chart

Nano Labs Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nano Labs (NA) Financials

Annual Income Statements for Nano Labs

Quarterly Income Statements for Nano Labs

Annual Cash Flow Statements for Nano Labs

Quarterly Cash Flow Statements for Nano Labs

Annual Balance Sheets for Nano Labs

Quarterly Balance Sheets for Nano Labs

Annual Metrics And Ratios for Nano Labs

Quarterly Metrics And Ratios for Nano Labs

Financials Breakdown Chart

Nano Labs Financials - Frequently Asked Questions

When does Nano Labs' financial year end?

How has Nano Labs' net income changed over the last 5 years?

What is Nano Labs' operating income?

How has Nano Labs' revenue changed over the last 5 years?

How much debt does Nano Labs have?

How much cash does Nano Labs have?

How has Nano Labs' book value per share changed over the last 5 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools